Immunotherapy represents an exciting advance in cancer treatment that harnesses the immune system to seek and destroy cancer cells. The programmed death 1 (PD-1) pathway dampens immune responses to tumor cells, and several clinical trials have shown
Source: Critical immunotherapy target marks dysfunctional regulatory T cells in brain cancer | Science Codex
Leave A Reply